Continued treatment of early virologic nonresponders or partial responders with bulevirtide monotherapy for chronic hepatitis delta leads to improvement in virologic and biochemical responses: Results from an integrated analysis at week 96

被引:0
|
作者
Lampertico, Pietro [1 ,2 ]
Wedemeyer, Heiner [5 ]
Brunetto, Maurizia [3 ,4 ]
Bogomolov, Pavel [7 ]
Stepanova, Tatyana [8 ]
Bourliere, Marc [9 ]
Fontaine, Helene [13 ]
Chee, Grace M. [13 ]
Manuilov, Dmitry [13 ]
An, Qi [13 ]
Freismuth, Aurelie [14 ]
Lau, Audrey [13 ]
Da, Ben [13 ]
Flaherty, John F. [13 ]
Mercier, Renee-Claude [13 ]
Frenette, Catherine [13 ]
Osinusi, Anu [13 ]
Gherlan, George Sebastian [15 ,16 ]
Streinu-Cercel, Adrian [17 ]
Zeuzem, Stefan [6 ]
Cornberg, Markus [5 ]
Roulot, Dominique [10 ]
Zoulim, Fabien [11 ]
Aleman, Soo [18 ]
Asselah, Tarik [12 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[2] Univ Milan, CRC AM & A Migliavacca Ctr Study Liver Dis, Milan, Italy
[3] Univ Hosp Pisa, Hepatol Unit, Reference Ctr Tuscany Reg Chron Liver Dis & Canc, Pisa, Italy
[4] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[5] Hannover Med Sch, Clin Gastroenterol Hepatol Infect Dis & Endocrino, Hannover, Germany
[6] Univ Hosp Frankfurt, Frankfurt, Germany
[7] Moscow Reg Clin Res Inst, State Budgetary Inst Hlth Care Moscow Reg, Moscow, Russia
[8] LLC Clin Modern Med, Moscow, Russia
[9] Hop St Joseph, Marseille, France
[10] Univ Sorbonne Paris Nord, Bobigny, France
[11] Hosp Croix Rousee, Lyon, France
[12] Univ Paris, Hop Beaujon, Clichy, France
[13] Gilead Sci Pty Ltd, Foster City, CA USA
[14] Gilead Sci Pty Ltd, Melbourne, Australia
[15] Carol Davila Univ Med & Pharm, Bucharest, Romania
[16] Dr Victor Babes Fdn, Bucharest, Romania
[17] Matei Bals Natl Inst Infect Dis, Bucharest, Romania
[18] Karolinska Inst, Karolinska Univ Hosp, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
278
引用
收藏
页码:102 / 103
页数:2
相关论文
共 34 条
  • [1] CONTINUED TREATMENT OF EARLY VIROLOGIC NON-RESPONDER OR PARTIAL RESPONDERS WITH BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS D LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES: RESULTS FROM AN INTEGRATED ANALYSIS AT WEEK 96
    Lampertico, Pietro
    Wedemeyer, Heiner
    Brunetto, Maurizia R.
    Bogomolov, Pavel
    Bourliere, Marc
    Fontaine, Helene
    Chee, Grace
    Manuilov, Dmitry
    Lau, Qi An Audrey H.
    Da, Ben L.
    Flaherty, John F.
    Mercier, Renee-Claude
    Frenette, Catherine
    Osinusi, Anu O.
    Sebastian Gherlan, George
    Zeuzem, Stefan
    Cornberg, Markus
    Roulot, Dominique M.
    Zoulim, Fabien
    Aleman, Soo
    Asselah, Tarik
    HEPATOLOGY, 2023, 78 : S67 - S70
  • [2] CONTINUED TREATMENT OF EARLY NONRESPONDER OR PARTIAL VIROLOGIC RESPONDERS WITH BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) THROUGH WEEK 96 LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES
    Lampertico, Pietro
    Wedemeyer, Heiner
    Brunetto, Maurizia
    Bogomolov, Pavel
    Stepanova, Tatyana
    Ciesek, Sandra
    Berger, Annemarie
    Manuilov, Dmitry
    An, Qi
    Lau, Audrey
    Da, Ben
    Flaherty, John
    Mercier, Renee-Claude
    Zeuzem, Stefan
    Cornberg, Markus
    Buti, Maria
    Aleman, Soo
    GUT, 2023, 72 (SUPPL_3) : A101 - A102
  • [3] CONTINUED TREATMENT OF EARLY NONRESPONDER OR PARTIAL VIROLOGIC RESPONDERS WITH BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) THROUGH WEEK 96 LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES
    Lampertico, Pietro
    Wedemeyer, Heiner
    Brunetto, Maurizia
    Bogomolov, Pavel
    Stepanova, Tatyana
    Ciesek, Sandra
    Berger, Annemarie
    Manuilov, Dmitry
    An, Qi
    Lau, Audrey
    Da, Ben
    Flaherty, John
    Mercier, Renee-Claude
    Zeuzem, Stefan
    Cornberg, Markus
    Buti, Maria
    Aleman, Soo
    GUT, 2023, 72 : A101 - A102
  • [4] Continued treatment of early non-responder or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis D through week 96 leads to improvement in virologic and biochemical responses
    Lampertico, Pietro
    Wedemeyer, Heiner
    Brunetto, Maurizia
    Bogomolov, Pavel
    Stepanova, Tatyana
    Ciesek, Sandra
    Berger, Annemarie
    Manuilov, Dmitry
    An, Qi
    Lau, Audrey
    Da, Ben
    Flaherty, John F.
    Mercier, Renee-Claude
    Zeuzem, Stefan
    Cornberg, Markus
    Buti, Maria
    Aleman, Soo
    JOURNAL OF HEPATOLOGY, 2023, 78 : S113 - S114
  • [5] Efficacy of bulevirtide as monotherapy for chronic hepatitis delta: Week 48 results from an integrated analysis
    Freismuth, A.
    Lampertico, P.
    Aleman, S.
    Blank, A.
    Bogomolov, P.
    Chulanov, V.
    Mamonova, N.
    Morozov, V.
    Sagalova, O.
    Stepanova, T.
    Suri, V.
    Manuilov, D.
    Ye, L.
    Flaherty, J. F.
    Osinusi, A. O.
    Cornberg, M.
    Brunetto, M.
    Wedemeyer, H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 69 - 69
  • [6] SIMILAR RATES OF BIOCHEMICAL RESPONSE ARE OBSERVED ACROSS VIROLOGIC RESPONSE CATEGORIES OVER 96 WEEKS OF BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA
    Lampertico, Pietro
    Asselah, Tarik
    Chulanov, Vladimir
    Bogomolov, Pavel
    Stepanova, Tatyana
    Cornberg, Markus
    Manuilov, Dmitry
    Li, Mingyang
    Lau, Audrey
    Da, Ben
    Tedesco, Dana
    Chee, Grace
    Brunetto, Maurizia
    Zeuzem, Stefan
    Zoulim, Fabien
    Wedemeyer, Heiner
    Aleman, Soo
    HEPATOLOGY, 2024, 80 : S131 - S132
  • [7] Similar Rates of Biochemical Response Are Observed Across Virologic Response Categories Over 96 Weeks of Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta
    Lampertico, P.
    Asselah, T.
    Chulanov, V.
    Bogomolov, P.
    Stepanova, T.
    Cornberg, M.
    Manuilov, D.
    Li, M.
    Lau, A. H.
    Da, B. L.
    Tedesco, D.
    Chee, G. M.
    Brunetto, M. R.
    Zeuzem, S.
    Zoulim, F.
    Wedemeyer, H.
    Aleman, S.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S57 - S58
  • [8] Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis
    Lampertico, P.
    Aleman, S.
    Blank, A.
    Bogomolov, P.
    Chulanov, V.
    Mamonova, N.
    Morozov, V.
    Sagalova, O.
    Stepanova, T.
    Suri, V.
    Manuilov, D.
    Ye, L.
    Flaherty, J. F.
    Osinusi, A.
    Cornberg, M.
    Brunetto, M.
    Wedemeyer, H.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S73 - S73
  • [9] EFFICACY OF BULEVIRTIDE AS MONOTHERAPY FOR CHRONIC HEPATITIS D (CHD): WEEK 48 RESULTS FROM AN INTEGRATED ANALYSIS
    Lampertico, Pietro
    Aleman, Soo
    Blank, Antje
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Suri, Vithika
    Manuilov, Dmitry
    Ye, Lei
    Flaherty, John F.
    Osinusi, Anu O.
    Cornberg, Markus
    Brunetto, Maurizia
    Wedemeyer, Heiner
    HEPATOLOGY, 2022, 76 : S228 - S230
  • [10] Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(-) chronic hepatitis B patients (study ETV-027)
    Shouval, D.
    Akarca, U. S.
    Hatzis, G.
    Kitis, G.
    Lai, C. L.
    Cheinquer, H.
    Chang, T. T.
    Zink, R.
    Zhu, J.
    Brett-Smith, H.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S21 - S22